Codex Capital Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Codex Capital Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9M	Hold	13,325	–	–	3.05%	13
2026 Q2	$6.68M	Sell	13,325 -25	-0.2%	-$12K	2.31%	17
2026 Q1	$6.56M	Hold	13,350	–	–	2.54%	15
2025 Q4	$7.74M	Buy	13,350 +475	+4%	+$269K	2.81%	14
2025 Q3	$6.24M	Hold	12,875	–	–	2.35%	17
2025 Q2	$5.22M	Hold	12,875	–	–	2.09%	19
2025 Q1	$6.41M	Hold	12,875	–	–	3.02%	12
2024 Q4	$6.7M	Hold	12,875	–	–	2.96%	12
2024 Q3	$7.96M	Hold	12,875	–	–	3.53%	9
2024 Q2	$7.12M	Buy	+12,875	New	+$7.38M	3.26%	11

Other funds holding TMO

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Codex Capital Asset Management's TMO Position: Q3 2026 in Review

Codex Capital Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 13,325 shares worth $9M. The position accounts for 3.05% of the portfolio, ranked #13.

Codex Capital Asset Management first reported a position in TMO in Q2 2024 and has held it in 10 quarters since. 1,615 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Codex Capital Asset Management held 13,325 shares of Thermo Fisher Scientific worth $9M as of Q3 2026.
Codex Capital Asset Management left its Thermo Fisher Scientific share count unchanged in Q3 2026.
Thermo Fisher Scientific made up 3.05% of Codex Capital Asset Management's portfolio in Q3 2026, its #13 holding.
Codex Capital Asset Management first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 10 quarters since.
1,615 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Codex Capital Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.